Annual EBITDA
-$32.61 M
+$14.42 M+30.66%
December 31, 2023
Summary
- As of February 22, 2025, SNSE annual EBITDA is -$32.61 million, with the most recent change of +$14.42 million (+30.66%) on December 31, 2023.
- During the last 3 years, SNSE annual EBITDA has fallen by -$14.40 million (-79.13%).
- SNSE annual EBITDA is now -157.39% below its all-time high of -$12.67 million, reached on December 31, 2018.
Performance
SNSE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$6.90 M
-$110.00 K-1.62%
September 30, 2024
Summary
- As of February 22, 2025, SNSE quarterly EBITDA is -$6.90 million, with the most recent change of -$110.00 thousand (-1.62%) on September 30, 2024.
- Over the past year, SNSE quarterly EBITDA has increased by +$154.00 thousand (+2.18%).
- SNSE quarterly EBITDA is now -126.97% below its all-time high of -$3.04 million, reached on March 31, 2020.
Performance
SNSE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$28.38 M
-$141.00 K-0.50%
September 30, 2024
Summary
- As of February 22, 2025, SNSE TTM EBITDA is -$28.38 million, with the most recent change of -$141.00 thousand (-0.50%) on September 30, 2024.
- Over the past year, SNSE TTM EBITDA has increased by +$4.23 million (+12.97%).
- SNSE TTM EBITDA is now -436.83% below its all-time high of -$5.29 million, reached on December 31, 2019.
Performance
SNSE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SNSE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.7% | +2.2% | +13.0% |
| 3 y3 years | -79.1% | +42.9% | +39.6% |
| 5 y5 years | -157.4% | +42.9% | +39.6% |
SNSE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.7% | -2.1% | +47.2% | -0.5% | +39.6% |
| 5 y | 5-year | -126.3% | +30.7% | -127.0% | +47.2% | -436.8% | +39.6% |
| alltime | all time | -157.4% | +30.7% | -127.0% | +47.2% | -436.8% | +39.6% |
Sensei Biotherapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.90 M(+1.6%) | -$28.38 M(+0.5%) |
| Jun 2024 | - | -$6.79 M(-11.0%) | -$28.24 M(-7.3%) |
| Mar 2024 | - | -$7.63 M(+8.2%) | -$30.46 M(-6.6%) |
| Dec 2023 | -$32.61 M(-30.7%) | -$7.05 M(+4.4%) | -$32.61 M(-13.4%) |
| Sep 2023 | - | -$6.76 M(-25.0%) | -$37.64 M(-14.3%) |
| Jun 2023 | - | -$9.02 M(-7.8%) | -$43.94 M(-2.3%) |
| Mar 2023 | - | -$9.78 M(-19.1%) | -$44.97 M(-4.4%) |
| Dec 2022 | -$47.02 M | -$12.09 M(-7.5%) | -$47.02 M(+7.7%) |
| Sep 2022 | - | -$13.06 M(+30.1%) | -$43.67 M(+9.3%) |
| Jun 2022 | - | -$10.04 M(-15.1%) | -$39.94 M(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$11.83 M(+35.5%) | -$39.40 M(+11.2%) |
| Dec 2021 | -$35.44 M(+94.7%) | -$8.73 M(-6.5%) | -$35.44 M(+11.7%) |
| Sep 2021 | - | -$9.34 M(-1.8%) | -$31.71 M(+14.6%) |
| Jun 2021 | - | -$9.50 M(+20.7%) | -$27.68 M(+20.2%) |
| Mar 2021 | - | -$7.87 M(+57.2%) | -$23.03 M(+26.5%) |
| Dec 2020 | -$18.20 M(+26.3%) | -$5.01 M(-5.5%) | -$18.20 M(-1.5%) |
| Sep 2020 | - | -$5.30 M(+9.2%) | -$18.48 M(+40.2%) |
| Jun 2020 | - | -$4.86 M(+59.7%) | -$13.18 M(+58.3%) |
| Mar 2020 | - | -$3.04 M(-42.5%) | -$8.33 M(+57.5%) |
| Dec 2019 | -$14.41 M(+13.8%) | -$5.29 M | -$5.29 M |
| Dec 2018 | -$12.67 M | - | - |
FAQ
- What is Sensei Biotherapeutics annual EBITDA?
- What is the all time high annual EBITDA for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics annual EBITDA year-on-year change?
- What is Sensei Biotherapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics quarterly EBITDA year-on-year change?
- What is Sensei Biotherapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics TTM EBITDA year-on-year change?
What is Sensei Biotherapeutics annual EBITDA?
The current annual EBITDA of SNSE is -$32.61 M
What is the all time high annual EBITDA for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high annual EBITDA is -$12.67 M
What is Sensei Biotherapeutics annual EBITDA year-on-year change?
Over the past year, SNSE annual EBITDA has changed by +$14.42 M (+30.66%)
What is Sensei Biotherapeutics quarterly EBITDA?
The current quarterly EBITDA of SNSE is -$6.90 M
What is the all time high quarterly EBITDA for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high quarterly EBITDA is -$3.04 M
What is Sensei Biotherapeutics quarterly EBITDA year-on-year change?
Over the past year, SNSE quarterly EBITDA has changed by +$154.00 K (+2.18%)
What is Sensei Biotherapeutics TTM EBITDA?
The current TTM EBITDA of SNSE is -$28.38 M
What is the all time high TTM EBITDA for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high TTM EBITDA is -$5.29 M
What is Sensei Biotherapeutics TTM EBITDA year-on-year change?
Over the past year, SNSE TTM EBITDA has changed by +$4.23 M (+12.97%)